De-escalating and escalating treatments for early-stage breast cancer:the St.Gallen International Expert Consensus Conference on the Primary Therapy of Early Breast Cancer 2017. CURIGLIANO G,BURSTEIN H J,P WINER
De-escalating and escalating treatments for early-stage breast cancer: the St. Gallen International Expert Consensus Conference on the Primary Therapy of Early Breast Cancer 2017 Annals of Oncology, Volume 28, Issue 8, August 2017, Pages 1700-1712 G Curigliano, H.J. Burstein, E.P. Winer, M...
Your doctor will think about a few things before they recommend a treatment for you: The type ofbreast canceryou have The size of your tumor and how far the cancer has spread in your body, called the stage of your disease Whether your tumor has things called receptors for HER2 protein, ...
Article Current Options for Treatment Learn about your treatment options for early stage II and III HR+/HER2- breast cancer.Explore More Article Choosing What Is Best for You It is important to have a say in your treatment for HR+/HER2- early breast cancer. Learn the best way to do that...
Building on past success in breast cancer research and development, Pfizer is developing a compelling pipeline of next-generation molecules targeting cell-cycle dysregulation, each with a unique and differentiated profile. Pfizer’s CDK inhibitor early-stage pipeline leverages next-generation molecules that...
breast cancer prevention and early detection. In addition, the progression of tumor is influenced by various factors operating through distinct mechanisms (such as tumor stemness, intra-tumoral microbiota, and circadian rhythms), and a comprehensive investigation into these mechanisms is essential for ...
Breast canceris the most common cancer worldwide, with more than 2.26 million new cases of breast cancer diagnosed in 20201. Whilebreast cancer is prevalent around the worldit is a highly treatable disease when detected at an early stage. With new advances and developments...
Anderson Cancer Center, Houston, 1989, pp. 389–397. Google Scholar Peters WP, Davis R, Shpall EJ, et al: Adjuvant chemotherapy involving high-dose combination cyclophosphamide, cisplatin and carmustine and autologous bone marrow support for stage II/III breast cancer involving ten or more ...
Normally, breast cells shift between an early, fast-growing stage and a mature, stable one. Cancer cells take advantage of this process, initially using it to multiply and later to evade detection within the body. The team focused on a type of protein called OVOL, which helps cells mature...
In breast cancer trials, Avastin has been effective at choking off the blood supply that tumors need to grow and spread. It is now being tested on women who are newly diagnosed. "Our hope really is that in those early-stage patients this will prevent recurrences and ultimately cure more wom...